Group One Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Group One Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.08M	Sell	5,700 -20,100	-78%	-$3.51M	﹤0.01%	2639
2025 Q4	$4.39M	Buy	25,800 +17,600	+215%	+$2.7M	0.01%	1623
2025 Q3	$1.08M	Sell	8,200 -73,400	-90%	-$8.8M	﹤0.01%	2954
2025 Q2	$8.66M	Sell	81,600 -22,200	-21%	-$2.41M	0.02%	921
2025 Q1	$12.9M	Buy	103,800 +93,500	+908%	+$12.2M	0.04%	508
2024 Q4	$1.27M	Sell	10,300 -54,700	-84%	-$6.45M	﹤0.01%	2332
2024 Q3	$7.24M	Sell	65,000 -13,300	-17%	-$1.46M	0.02%	783
2024 Q2	$8.36M	Buy	78,300 +400	+0.5%	+$44K	0.03%	536
2024 Q1	$9.38M	Buy	77,900 +76,100	+4,228%	+$9.32M	0.04%	472
2023 Q4	$221K	Sell	1,800 -2,200	-55%	-$275K	﹤0.01%	3782
2023 Q3	$518K	Sell	4,000 -3,000	-43%	-$400K	﹤0.01%	2875
2023 Q2	$868K	Sell	7,000 -2,000	-22%	-$269K	﹤0.01%	2489
2023 Q1	$1.32M	Sell	9,000 -23,300	-72%	-$3.45M	﹤0.01%	1898
2022 Q4	$5.15M	Sell	32,300 -85,200	-73%	-$12.5M	0.01%	1124
2022 Q3	$15.7M	Buy	117,500 +84,100	+252%	+$12.8M	0.03%	502
2022 Q2	$5.21M	Sell	33,400 -2,000	-6%	-$308K	0.01%	1262
2022 Q1	$5.51M	Buy	35,400 +11,400	+48%	+$1.65M	0.01%	1474
2021 Q4	$3.06M	Sell	24,000 -1,200	-5%	-$158K	﹤0.01%	2165
2021 Q3	$3.28M	Sell	25,200 -14,400	-36%	-$2.18M	﹤0.01%	2140
2021 Q2	$7.04M	Sell	39,600 -61,100	-61%	-$10.6M	0.01%	1381
2021 Q1	$16.6M	Buy	100,700 +21,800	+28%	+$3.59M	0.02%	639
2020 Q4	$13M	Buy	78,900 +70,600	+851%	+$10.5M	0.02%	656
2020 Q3	$1.18M	Buy	8,300 +8,200	+8,200%	+$1.02M	﹤0.01%	2047
2020 Q2	$11K	Hold	100	–	–	﹤0.01%	5077
2020 Q1	$10K	Buy	+100	New	+$12.9K	﹤0.01%	4567
2019 Q4	–	Sell	-14,000	Closed	-$1.79M	–	5343
2019 Q3	$1.79M	Buy	14,000 +13,800	+6,900%	+$1.85M	0.01%	1294
2019 Q2	$29K	Buy	200 +100	+100%	+$13.4K	﹤0.01%	4031
2019 Q1	$14K	Buy	+100	New	+$13K	﹤0.01%	4154
2018 Q4	–	Sell	-4,600	Closed	-$773K	–	5122
2018 Q3	$773K	Sell	4,600 -12,300	-73%	-$2.12M	0.01%	1909
2018 Q2	$2.91M	Buy	16,900 +8,900	+111%	+$1.45M	0.02%	859
2018 Q1	$1.21M	Sell	8,000 -5,100	-39%	-$748K	0.01%	1366
2017 Q4	$1.76M	Sell	13,100 -19,400	-60%	-$2.69M	0.01%	1276
2017 Q3	$4.75M	Buy	32,500 +25,300	+351%	+$3.83M	0.04%	531
2017 Q2	$1.12M	Sell	7,200 -3,400	-32%	-$520K	0.01%	1362
2017 Q1	$1.54M	Sell	10,600 -29,300	-73%	-$3.82M	0.02%	1039
2016 Q4	$4.35M	Buy	39,900 +3,300	+9%	+$368K	0.04%	491
2016 Q3	$4.45M	Sell	36,600 -2,500	-6%	-$337K	0.05%	468
2016 Q2	$5.53M	Buy	39,100 +12,900	+49%	+$1.9M	0.07%	352
2016 Q1	$3.42M	Sell	26,200 -27,000	-51%	-$3.36M	0.05%	510
2015 Q4	$7.48M	Buy	53,200 +29,200	+122%	+$4.05M	0.09%	234
2015 Q3	$3.19M	Buy	24,000 +2,200	+10%	+$379K	0.04%	540
2015 Q2	$3.84M	Sell	21,800 -14,100	-39%	-$2.53M	0.05%	425
2015 Q1	$6.2M	Sell	35,900 -74,400	-67%	-$12.8M	0.1%	195
2014 Q4	$18.1M	Buy	110,300 +7,300	+7%	+$1.21M	0.27%	56
2014 Q3	$16.5M	Buy	103,000 +15,300	+17%	+$2.35M	0.25%	53
2014 Q2	$12.9M	Sell	87,700 -103,700	-54%	-$14.4M	0.2%	74
2014 Q1	$26.5M	Sell	191,400 -23,000	-11%	-$3.46M	0.45%	24
2013 Q4	$27.1M	Buy	214,400 +116,400	+119%	+$12M	0.41%	29
2013 Q3	$9.01M	Buy	98,000 +67,000	+216%	+$5.4M	0.17%	94
2013 Q2	$2.13M	Buy	+31,000	New	+$1.89M	0.05%	393

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Group One Trading's JAZZ Position: Q1 2026 in Review

Group One Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 6,815 shares — an estimated $1.19M sold.

Group One Trading first reported a position in JAZZ in Q2 2013 and held it in 31 quarters. The position peaked at $11.2M in Q3 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Group One Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 6,815 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.19M.
Group One Trading first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 31 quarters.
Group One Trading's Jazz Pharmaceuticals position peaked at $11.2M in Q3 2014.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.